These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19798812)

  • 21. Interferon beta-1a-induced depression and suicidal ideation in multiple sclerosis.
    Lana-Peixoto MA; Teixeira AL; Haase VG
    Arq Neuropsiquiatr; 2002 Sep; 60(3-B):721-4. PubMed ID: 12364937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythema elevatum et diutinum, multiple sclerosis and interferon beta.
    Gil M; Chizzolini C; Kaya G; Hauser C
    Dermatology; 2004; 209(1):75-6. PubMed ID: 15237277
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis.
    Mahe J; Meurette A; Moreau A; Vercel C; Jolliet P
    Drug Des Devel Ther; 2013; 7():723-8. PubMed ID: 23950639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a.
    Schott E; Paul F; Wuerfel JT; Zipp F; Rudolph B; Wiedenmann B; Baumgart DC
    World J Gastroenterol; 2007 Jul; 13(26):3638-40. PubMed ID: 17659718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment.
    Blake G; Murphy S
    Neurology; 1997 Dec; 49(6):1747-8. PubMed ID: 9409387
    [No Abstract]   [Full Text] [Related]  

  • 26. [Appearance of immune thyroid diseases during beta-interferon therapy of multiple sclerosis].
    Buchinger W; Niederwieser G; Rainer F
    Dtsch Med Wochenschr; 1999 Dec; 124(48):1473. PubMed ID: 10615332
    [No Abstract]   [Full Text] [Related]  

  • 27. Transfer of interferon β-1a into human breastmilk.
    Hale TW; Siddiqui AA; Baker TE
    Breastfeed Med; 2012 Apr; 7(2):123-5. PubMed ID: 21988602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcified subcutaneous nodules: a long-term complication of interferon beta-1a therapy.
    Macbeth AE; Kendall BR; Smith A; Saldanha G; Harman KE
    Br J Dermatol; 2007 Sep; 157(3):624-5. PubMed ID: 17596164
    [No Abstract]   [Full Text] [Related]  

  • 29. Local reactions associated with subcutaneous injections of both beta-interferon 1a and 1b.
    García-F-Villalta M; Daudén E; Sánchez J; Fraga J; Ramo C; García-Díez A
    Acta Derm Venereol; 2001 May; 81(2):152. PubMed ID: 11501663
    [No Abstract]   [Full Text] [Related]  

  • 30. Scleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on interferon beta-1a.
    Kumar N; Rodriguez M
    Mult Scler; 2004 Feb; 10(1):85-6. PubMed ID: 14760958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency and magnitude of interferon β neutralizing antibodies in the evaluation of interferon β immunogenicity in patients with multiple sclerosis.
    Grossberg SE; Oger J; Grossberg LD; Gehchan A; Klein JP
    J Interferon Cytokine Res; 2011 Mar; 31(3):337-44. PubMed ID: 21226608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Panniculitis and lipoatrophy after subcutaneous injection of interferon beta-1b in a patient with multiple sclerosis.
    O'Sullivan SS; Cronin EM; Sweeney BJ; Bourke JF; Fitzgibbon J
    J Neurol Neurosurg Psychiatry; 2006 Dec; 77(12):1382-3. PubMed ID: 16782776
    [No Abstract]   [Full Text] [Related]  

  • 33. Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis.
    Mohr DC; Likosky W; Dwyer P; Van Der Wende J; Boudewyn AC; Goodkin DE
    Arch Neurol; 1999 Oct; 56(10):1263-5. PubMed ID: 10520943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic lupus erythematosus induced by interferon β1 therapy in a patient with multiple sclerosis.
    Bahri DM; Khiari H; Essouri A; Laadhar L; Zaraa I; Mrabet A; Meddeb N; Sellami S
    Fundam Clin Pharmacol; 2012 Apr; 26(2):210-1. PubMed ID: 21323997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: Case Report.
    Viana de Andrade AC; Brito ÉA; Harris OM; Viana de Andrade AP; Leite MF; Pithon MM
    Int J Dermatol; 2015; 54(5):e140-5. PubMed ID: 25208461
    [No Abstract]   [Full Text] [Related]  

  • 36. Mixed panniculitis secondary to interferon beta-1a therapy in a woman with multiple sclerosis.
    Cuesta L; Moragón M; Pérez-Crespo M; Onrubia J; García M
    Actas Dermosifiliogr; 2013 Apr; 104(3):257-9. PubMed ID: 22980355
    [No Abstract]   [Full Text] [Related]  

  • 37. Arthritis during interferon beta-1b treatment in multiple sclerosis.
    Altintas A; Alici Y; Melikoğlu M; Siva A
    Mult Scler; 2002 Dec; 8(6):534-6. PubMed ID: 12474998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of myasthenia gravis in two patients with multiple sclerosis following interferon beta treatment.
    Dionisiotis J; Zoukos Y; Thomaides T
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):1079. PubMed ID: 15201386
    [No Abstract]   [Full Text] [Related]  

  • 39. Embolia cutis medicamentosa following interferon beta injection.
    Koontz D; Alshekhlee A
    Mult Scler; 2007 Nov; 13(9):1203-4. PubMed ID: 17967846
    [No Abstract]   [Full Text] [Related]  

  • 40. [Subacute cutaneous lupus erythematosus and interferon beta-1 a].
    Schmutz J; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2000 Feb; 127(2):237. PubMed ID: 10739993
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.